- Aurora Cannabis (TSX:ACB) is expanding its pastille offerings in Australia, marking a significant step in the company’s move to diversify its range of medical cannabis products
- This expansion aims to meet the various needs and interests of patients seeking effective and convenient medical cannabis options
- Medical cannabis pastilles offer several key benefits, including easy oral intake and prolonged effects that provide long-lasting relief after digestion
- Aurora Cannabis stock (TSX:ACB) last traded at C$8.30
Aurora Cannabis (TSX:ACB) is expanding its pastille offerings in Australia, marking a significant step in the company’s move to diversify its range of medical cannabis products.
This expansion aims to meet the various needs and interests of patients seeking effective and convenient medical cannabis options.
Medical cannabis pastilles offer several key benefits, including…
